Skip to main content
. 2023 Oct 30;55:11626. doi: 10.2340/jrm.v55.11626

Fig. 4.

Fig. 4

Change in 12-month costs before and after onabotulinumtoxinA treatment based on length of time from stroke diagnosis. p-values < 0.0001 were significant for difference in costs before and after treatment with onabotulinumtoxinA.